Sumitomo Pharma Hits Day High with 7.71% Surge to JPY 2,212.00

Sumitomo Pharma Co., Ltd. has experienced a significant surge in its stock price, gaining 7.71% on April 15, 2026. The stock reached an intraday high of JPY 2,212.00, reflecting strong market activity. Over the past year, Sumitomo Pharma has outperformed the Japan Nikkei 225 index, generating an impressive return of 281.98% compared to the index's 69.65%. The company's financial metrics indicate robust performance, with a net profit of JPY 96,471 million and an operating cash flow reaching JPY 53,277 million. Sumitomo Pharma's return on equity stands at 58.26%, showcasing its effective management of shareholder equity. The stock's price-to-earnings ratio is 14.00, suggesting a favorable valuation relative to its earnings. In terms of recent performance, Sumitomo Pharma has shown a 19.46% increase over the past month, significantly outpacing the Japan Nikkei 225's 8.02% gain. With a market capitalization of JPY 1,094,225 million, the company continues to solidify its position in the pharmaceuticals and biotechnology sector.